Sexual functioning in patients with hepatocellular carcinoma

Cancer

Volumn 104, Issue 10, 2005, Pages 2234-2243

  Steel, Jennifer ^a   Hess, Stephanie A ^a   Tunke, Laura ^a   Chopra, Kapil ^a   Carr, Brian I ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Chronic liver disease (CLD); General population; Hepatocellular carcinoma (HCC); Quality of life (QOL); Sexual functioning

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FUNCTIONAL ASSESSMENT OF CANCER THERAPY HEPATOBILIARY; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL DYSFUNCTION; SEXUAL HISTORY QUESTIONNAIRE; SEXUALITY;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 27644541454     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21450     Document Type: Article

References (29)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. JAMA. 1999;281:537-544.
2. Barni S, Mondin R. Sexual dysfunction in treated breast cancer patients. Ann Oncol. 1997;8:149-153.
3. Gruber U, Fegg M, Buchmann M, Kolb HJ, Hiddemann W. The long-term psychosocial effects of haematopoetic stem cell transplantation. Ear J Cancer Care (Engl). 2003;12:249-256.
4. Rosing D, Berberich HJ. Disease- and treatment related sexual disorders after radical prostatectomy. A biopsychosocial consideration [in German]. Urologe A. 2004;43:291-295.
5. Marks DI, Crilley P, Nezu CM, Nezu AM. Sexual dysfunction prior to high-dose chemotherapy and bone marrow transplantation. Bone Marrow Transplant. 1996;17:595-599.
6. Andersen BL. Surviving cancer: the importance of sexual self-concept. Med Pediatr Oncol. 1999;33:15-23.
7. Clayton AH, McGarvey EL, Clavet GJ. The changes in sexual functioning questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull. 1997;33:731-745.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1994.
9. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-579.
10. Heffernan N, Cella D, Webster K, et al. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol. 2002;20:2229-2239.
11. Medical Economics Data Production Company. Physician's Desk Reference. Montvale, NH: Medical Economics Data Production Company, 2003.
12. Zifroni A, Schiavi RC, Schnaffner F. Sexual function and testosterone levels in men with nonalcoholic liver disease. Hepatology. 1991;14:479-482.
13. Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J Pain Symptom Manage. 2003;26:1055-1061.
14. Baker HW, Burger HG, de Kretser DM, et al. A study of the endocrine manifestations of hepatic cirrhosis. Q J Med. 1976;45:145-178.
15. Jensen SB, Gluud C. Sexual dysfunction in men with alcoholic liver cirrhosis. A comparative study. Liver. 1985;5:94-100.
16. Nolle W, Schindler CG, Figulla HR, et al. Increase of serum estradiol in cirrhotic men treated by transjugular intrahepatic portosystemic stent shunt. J Hepatol. 2001;34:818-824.
17. Van Steenbergen W. Alcohol, liver cirrhosis and disorders in sex hormone metabolism [in Dutch]. Acta Clin Belg. 1993; 48:269-2B3.
18. Wang YJ, Wu JC, Lee SD, Tsai YT, Lo KJ. Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men. Hepatogastroenterology. 1991;38:531-534.
19. Coldwell DM, Stokes KR, Yakes WF. Embolotherapy: agents, clinical applications, and techniques. Radiographiec. 1994; 14:623-643.
20. Farinati F, Rinaldi M, Del Prato S, et al. Fasting hyperglycaemia following trans-catheter arterial chemo-embolization for hepatocellular carcinoma in cirrhosis. Ital J Gastroenterol Hepatol. 1999;29:427-433.
21. Saito K, Inoue S, Saito T, et al. Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma. Gut. 2002;51:100-104.
22. d'Arville CN, Johnson PJ. Growth factors, endocrine aspects and hormonal treatment in hepatocellular carcinoma-an overview [review]. J Steroid Biochem Mol Biol. 1990;37:1007-1012.
23. Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10:19-28.
24. Gambert SR. Alcohol abuse: medical effects of heavy drinking in late life. Geriatrics. 1997;52:30-37.
25. Van Lankveld JJ, Grotjohann Y. Psychiatric comorbidity in heterosexual couples with sexual dysfunction assessed with the composite international diagnostic interview. Arch Sex Behav. 2000;29:479-498.
26. Cella D, Hahn E, Dineen K. Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res. 2002;11:207-221.
27. Dahn JR, Penedo FJ, Gonzalez JS, et al. Sexual functioning and quality of life after prostate cancer treatment: considering sexual desire. Urology. 2004;63:273-277.
28. Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JL. Prevalence of erectile dysfunction: a systematic review of population-based studies. Int J Impot Res. 2002;14:422-432.
29. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M. The multinational men's attitudes to life events and sexuality (MALES) study I: prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004;20:607-617.